SPONSORS
DIAMOND SPONSOR
Amgen harnesses the best of biology and technology to make people’s lives easier, fuller, and longer. We draw upon our deep knowledge of science to push beyond what’s known today. With roots in the biotech revolution, we are one of the world’s leading independent biotech companies – fighting the toughest diseases and helping millions of people globally.
PLATINUM SPONSOR
Novartis is an innovative medicines company dedicated to reimagining medicine to improve and extend people's lives. Headquartered in Basel, Switzerland, Novartis focuses on discovering, developing, and delivering transformative medicines that address serious diseases across key therapeutic areas including immunology, cardiovascular, renal and metabolic diseases, neuroscience, and oncology. Our medicines reach more than 300 million patients worldwide, supported by approximately 77,000 associates across more than 100 countries. Novartis combines advanced science, cutting-edge technology, and a deep commitment to patients to help address some of the world's most pressing healthcare challenges while advancing sustainable and equitable access to healthcare.
GOLD SPONSOR
AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy. AbbVie formed a new kind of enterprise – a biopharmaceutical company – with the stability, global scale, resources and commercial capabilities of a pharmaceutical company and the focus and culture of a biotech. Since the beginning, our mission hasn't wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers. Our mission is to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.
SILVER SPONSORS
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally.
We have three priorities designed to deliver our growth through innovation strategy.
Accelerate Innovative Science:
Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity
Deliver Growth and Therapy Area Leadership:
Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition
Be a Great Place to Work:
Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program.
Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet.
Roche is a healthcare company uniquely placed to prevent, stop and cure diseases by uniting leading science and technology across diagnostics, medicines and digital solutions. The company was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 100 countries around the world. It is dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities and healthcare systems. Across its Diagnostics and Pharmaceutical divisions, Roche focused on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals who care for them.
Our Purpose at Sandoz is clear: pioneering access for patients We focus on driving access to make a difference for patients and are already doing so in a very real way. How? We specialize in the development of generic and biosimilar medicines. That means we develop more affordable versions of high-quality medicines once their key patents have expired. For us, pioneering access for patients means going new ways in how we develop new products in line with patient needs, how we produce cutting-edge medicines at prices people can afford, and how we get the medicines to the patients who need them. As the leading supplier of such medicines – which account for around 80% of medicines worldwide – we make access to high-quality medicines more affordable. Why? Because medicines can only transform lives when they reach those who need them. While they can be powerful, originator medicines are often too expensive for many healthcare systems and patients. Developing off-patent medicines makes them more affordable and accessible. Going forward, we expect to make an even bigger difference to those who need affordable, sustainable and high-quality healthcare.
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
BRONZE SPONSORS
Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
NewBridge Pharmaceuticals, headquartered in Dubai, UAE, is a regional specialty company with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize U.S. FDA or EMA approved innovative therapeutics that address unmet medical needs into the Middle East and North Africa (MENA) regions.